Setmelanotide
Introduction Setmelanotide is a drug intended to treat hereditary obesity caused by an uncommon single-gene mutation. It is marketed under the Imcivree brand. Injection site reactions, skin hyperpigmentation (skin patches, skin darkening), headaches, and gastrointestinal side effects (abdominal pain, nausea, and diarrhea) are among the most frequent adverse effects. Additionally, setmelanotide has been linked to…